We are live on ! Find out more
PALI icon

Palisade Bio
PALI

15 hedge funds and large institutions have $2.03M invested in Palisade Bio in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0.04% less ownership

Funds ownership: 0.04% → 0.01% (-0.04%)

6% less funds holding

Funds holding: 16 → 15 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

80% less capital invested

Capital invested by funds: $10.1M → $2.03M (-$8.09M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$433K
2
SIG
Sargent Investment Group
Maryland
+$309K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$17.7K
4
Wells Fargo
Wells Fargo
California
+$17.7K
5
BlackRock
BlackRock
New York
+$11K

Top Sellers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
-$7.43M
2
Renaissance Technologies
Renaissance Technologies
New York
-$591K
3
UBS Group
UBS Group
Switzerland
-$59.7K
4
TRCT
Tower Research Capital (TRC)
New York
-$4K
5
VF
Virtu Financial
New York
-$2.21K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$645K +$17.7K +8 +3%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$454K +$433K +196 +594%
SIG
3
Sargent Investment Group
Maryland
$278K +$309K +140 New
SWIG
4
Strategic Wealth Investment Group
Kentucky
$141K – – –
SM
5
Sabby Management
Florida
$139K – – –
BlackRock
6
BlackRock
New York
$76K +$11K +5 +15%
State Street
7
State Street
Massachusetts
$75K – – –
PAG
8
Private Advisor Group
New Jersey
$62K +$6.63K +3 +11%
VF
9
Virtu Financial
New York
$47K -$2.21K -1 -4%
HighTower Advisors
10
HighTower Advisors
Illinois
$44K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$28K – – –
Wells Fargo
12
Wells Fargo
California
$16K +$17.7K +8 New
Morgan Stanley
13
Morgan Stanley
New York
$12K +$2.21K +1 +20%
UBS Group
14
UBS Group
Switzerland
$6K -$59.7K -27 -90%
EWM
15
Evermay Wealth Management
Virginia
$5K – – –
ACM
16
Altium Capital Management
New York
– -$7.43M -2,433 Closed
Renaissance Technologies
17
Renaissance Technologies
New York
– -$591K -194 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– -$4K -1 Closed

PALI Hedge Fund Activity: Q3 2021 in Review

15 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2021, worth a combined $2.03M — down 80% from $10.1M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PALI and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $433K. The largest seller was Altium Capital Management, exiting entirely with an estimated $7.43M sold.

  • 15 institutional investors held Palisade Bio (PALI) as of Q3 2021, down from 16 in Q2 2021.
  • Funds reported $2.03M of Palisade Bio stock for Q3 2021, down 80% quarter-over-quarter.
  • 2 funds opened new Palisade Bio positions in Q3 2021 and 3 closed out, a net change of -1 holder.
  • The largest Palisade Bio buyer in Q3 2021 was Geode Capital Management, an estimated $433K added.
  • The largest Palisade Bio seller in Q3 2021 was Altium Capital Management, an estimated $7.43M sold.

Based on aggregated 13F filings for Q3 2021.